Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Feb. 29, 2024	Feb. 28, 2023
Cash flows from operating activities:
Net income	$ 138,665	$ 125,500
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in income of unconsolidated joint ventures	(6,610)	(825)
Distributions of earnings from unconsolidated joint ventures	6,500	11
Amortization of debt issuance costs and premiums	860	835
Depreciation and amortization	9,335	8,712
Deferred income taxes	2,300	5,000
Stock-based compensation	7,921	5,867
Inventory impairments and land option contract abandonments	1,298	5,289
Changes in assets and liabilities:
Receivables	10,105	(25,303)
Inventories	(107,536)	101,293
Accounts payable, accrued expenses and other liabilities	(38,471)	(131,671)
Other, net	4,151	(791)
Net cash provided by operating activities	28,518	93,917
Cash flows from investing activities:
Contributions to unconsolidated joint ventures	(3,138)	(13,223)
Return of investments in unconsolidated joint ventures	0	5,100
Purchases of property and equipment, net	(9,454)	(8,838)
Net cash used in investing activities	(12,592)	(16,961)
Cash flows from financing activities:
Borrowings under revolving credit facility	0	170,000
Repayments under revolving credit facility	0	(220,000)
Payments on mortgages and land contracts due to land sellers and other loans	(917)	(237)
Issuance of common stock under employee stock plans	8,804	1,134
Stock repurchases	(50,000)	(75,000)
Tax payments associated with stock-based compensation awards	(16,505)	(9,748)
Payments of cash dividends	(16,355)	(12,476)
Net cash used in financing activities	(74,973)	(146,327)
Net decrease in cash and cash equivalents	(59,047)	(69,371)
Cash and cash equivalents at beginning of period	727,342	330,198
Cash and cash equivalents at end of period	$ 668,295	$ 260,827